About 3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome
3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome is a rare disease catalogued by Orphanet (ORPHA:445038). It is associated with the CLPB gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to 3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome trials.
Search ClinicalTrials.gov for "3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome" or filter by Orphanet code ORPHA:445038 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting 3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for 3-methylglutaconic aciduria-neonatal cataract-neurologic involvement-congenital neutropenia syndrome. Updated daily.